BREYANZI
Lisocabtagene maraleucel · KIT · Juno Therapeutics, Inc.
No Recall History
Plain English
BREYANZI is a kit containing lisocabtagene maraleucel. Manufactured by Juno Therapeutics, Inc..
Key Facts
- Brand Name
- BREYANZI
- Generic Name
- Lisocabtagene maraleucel
- NDC Code (Product)
73153-900- Manufacturer
- Juno Therapeutics, Inc.
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125714
- Marketing Start
- 02/05/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is BREYANZI used for?
BREYANZI contains Lisocabtagene maraleucel. It is a kit taken as directed. Consult your doctor for specific uses.
Is BREYANZI a controlled substance?
BREYANZI is not classified as a controlled substance by the DEA.
What is the generic name for BREYANZI?
The generic name for BREYANZI is Lisocabtagene maraleucel. There are no other listed brand versions of Lisocabtagene maraleucel.
What is the NDC code for BREYANZI ?
The NDC (National Drug Code) for BREYANZI is 73153-900, listed by Juno Therapeutics, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)